Clinical Trial Update: Rosiglitazone Effects on Cognition for Adults in Later Life [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining the effects of rosiglitazone on cognition in adults with mild cognitive impairment; current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: University of Washington | Conditions: Mild Cognitive Impairment | Phase 2 | Status: UNKNOWN